CD79A and selective IgA deficiency disease: As cases of severe anaphylaxis have rarely been reported in patients with severe IgA deficiency harboring anti-IgA IgE antibodies the administration of low-IgA formulations seems to show a better safety profile in those who have previously experienced severe allergic reactions (55).